These industry payments can't help but influence which plans brokers highlight for employers, says Eric Campbell, director of research at the University of Colorado Center for Bioethics and Humanities. "It's a classic conflict of interest," Campbell says. There's "a large body of virtually irrefutable evidence," Campbell says, that shows drug company payments to doctors influence the way they prescribe. "Denying this effect is like denying that gravity exists." And there's no reason, he says, to think brokers are any different.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045